Facet Life Sciences

Facet Life Sciences Makes Emerging Biotech Approvable. The pathway to FDA can be difficult to navigate when precedent is limited, and frameworks are thin. Facet specializes in helping emerging biotech teams understand what your program must demonstrate, how regulators are likely to evaluate the evidence, and what constitutes a viable, and ultimately, approvable, path forward. It’s a regulatory strategy that starts where it should: with your science and your goals. Not the other way around. Book a free 30-minute intro session with Facet.